Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 6/2023

16.12.2022

Presence of sinus rhythm at time of ablation in patients with persistent atrial fibrillation undergoing pulmonary vein isolation is associated with improved long-term arrhythmia outcomes

verfasst von: Lauren A. Eberly, Aung Lin, Joseph Park, Mirmilad Khoshnab, Lohit Garg, Jennifer Chee, Michael J. Kallan, Katie Walsh, Gregory E. Supple, Robert D. Schaller, Pasquale Santangeli, Michael P. Riley, Saman Nazarian, Jeffrey Arkles, Matthew Hyman, David Lin, Gustavo Guandalini, Ramanan Kumareswaran, Rajat Deo, Erica S. Zado, Andrew Epstein, David S. Frankel, David J. Callans, Francis E. Marchlinski, Sanjay Dixit

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Adverse structural and electrical remodeling underlie persistent atrial fibrillation (PersAF). Restoration of sinus rhythm (SR) prior to ablation in PersAF may improve the underlying substrate, thus improving arrhythmia outcomes. The aim of this study was to evaluate if the presence of SR at time of ablation is associated with improved long-term arrhythmia outcomes of a limited catheter ablation (CA) strategy in PersAF.

Methods

Patients with PersAF undergoing pulmonary vein isolation at our institution from 2014–2018 were included. We compared patients who presented for ablation in SR (by cardioversion and/or antiarrhythmic drugs [AADs]) to those who presented in AF. Primary outcome of interest was freedom from atrial arrhythmias (AAs) on or off AADs at 1 year after single ablation. Secondary outcomes included freedom from AAs on or off AADs overall, freedom from AAs off AADs at 1 year, and time to recurrent AF.

Results

Five hundred seventeen patients were included (322 presented in AF, 195 SR). The primary outcome was higher in those who presented for CA in SR as compared to AF (85.6% vs. 77.0%, p = 0.017). Freedom from AAs off AAD at 12 months was also higher in those presenting in SR (59.0% vs. 44.4%; p = 0.001) and time to recurrent AF was longer (p = 0.008). Presence of SR at CA was independently associated with the primary outcome at 12 months (OR 1.77; 95% CI 1.08–2.90) and overall (OR 1.89; 95% CI 1.26–2.82).

Conclusions

Presence of SR at time of ablation is associated with improved long-term arrhythmia outcomes of limited CA in PersAF.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2012;9:632-696.e621.CrossRefPubMed Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2012;9:632-696.e621.CrossRefPubMed
2.
Zurück zum Zitat Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, https://doi.org/10.1161/CIRCEP.116.004915 18 Packer D, Skanes A, Ambrogi F, Biganzoli E. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32–38. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, https://​doi.​org/​10.​1161/​CIRCEP.​116.​004915 18 Packer D, Skanes A, Ambrogi F, Biganzoli E. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32–38.
3.
Zurück zum Zitat Dixit S, Gerstenfeld EP, Ratcliffe SJ, Cooper JM, Russo AM, Kimmel SE, Callans DJ, Lin D, Verdino RJ, Patel VV, Zado E, Marchlinski FE. Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study. Heart Rhythm. 2008;5:174–81. https://doi.org/10.1016/j.hrthm.2007.09.024.CrossRefPubMed Dixit S, Gerstenfeld EP, Ratcliffe SJ, Cooper JM, Russo AM, Kimmel SE, Callans DJ, Lin D, Verdino RJ, Patel VV, Zado E, Marchlinski FE. Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study. Heart Rhythm. 2008;5:174–81. https://​doi.​org/​10.​1016/​j.​hrthm.​2007.​09.​024.CrossRefPubMed
4.
Zurück zum Zitat Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Pelosi F Jr, Strickberger SA, Morady F. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 2002;105:1077–81.CrossRefPubMed Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Pelosi F Jr, Strickberger SA, Morady F. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 2002;105:1077–81.CrossRefPubMed
5.
Zurück zum Zitat Haissaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y, Rostock T, Hsu LF, Bordachar P, Reuter S, Roudaut R, Clementy J, Jais P. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol. 2005;16:1138–47.CrossRefPubMed Haissaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y, Rostock T, Hsu LF, Bordachar P, Reuter S, Roudaut R, Clementy J, Jais P. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol. 2005;16:1138–47.CrossRefPubMed
8.
Zurück zum Zitat Dixit S, Marchlinski FE, Lin D, Callans DJ, Bala R, Riley MP, Garcia FC, Hutchinson MD, Ratcliffe SJ, Cooper JM, Verdino RJ, Patel VV, Zado ES, Cash NR, Killian T, Tomson TT, Gerstenfeld EP. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5:287–94. https://doi.org/10.1161/CIRCEP.111.966226.CrossRefPubMed Dixit S, Marchlinski FE, Lin D, Callans DJ, Bala R, Riley MP, Garcia FC, Hutchinson MD, Ratcliffe SJ, Cooper JM, Verdino RJ, Patel VV, Zado ES, Cash NR, Killian T, Tomson TT, Gerstenfeld EP. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5:287–94. https://​doi.​org/​10.​1161/​CIRCEP.​111.​966226.CrossRefPubMed
9.
Zurück zum Zitat Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P, Investigators STARAFII. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812–22. https://doi.org/10.1056/NEJMoa1408288.CrossRefPubMed Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P, Investigators STARAFII. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812–22. https://​doi.​org/​10.​1056/​NEJMoa1408288.CrossRefPubMed
11.
Zurück zum Zitat Yu HT, Shim J, Park J, Kim I-S, Kim T-H, Uhm J-S, Joung B, Lee MH, Kim Y-H, Pak H-N. Pulmonary vein isolation alone versus additional linear ablation in patients with persistent atrial fibrillation converted to paroxysmal type with antiarrhythmic drug therapy: a multicenter, prospective, randomized study. Circ Arrhythm Electrophysiol. 2017;10:e004915. https://doi.org/10.1161/CIRCEP.116.004915.CrossRefPubMed Yu HT, Shim J, Park J, Kim I-S, Kim T-H, Uhm J-S, Joung B, Lee MH, Kim Y-H, Pak H-N. Pulmonary vein isolation alone versus additional linear ablation in patients with persistent atrial fibrillation converted to paroxysmal type with antiarrhythmic drug therapy: a multicenter, prospective, randomized study. Circ Arrhythm Electrophysiol. 2017;10:e004915. https://​doi.​org/​10.​1161/​CIRCEP.​116.​004915.CrossRefPubMed
14.
Zurück zum Zitat January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC, AHA Task Force Members. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071–104. https://doi.org/10.1161/CIR.0000000000000040.CrossRefPubMed January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC, AHA Task Force Members. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071–104. https://​doi.​org/​10.​1161/​CIR.​0000000000000040​.CrossRefPubMed
16.
18.
Zurück zum Zitat Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation. 1997;96:3710–20.CrossRefPubMed Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation. 1997;96:3710–20.CrossRefPubMed
19.
Zurück zum Zitat Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54:230–46.CrossRefPubMed Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54:230–46.CrossRefPubMed
20.
Zurück zum Zitat Everett TH, Wilson EE, Verheule S, Guerra JM, Foreman S, Olgin JE. Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am J Physiol Heart Circ Physiol. 2006;291:H2911–23.CrossRefPubMed Everett TH, Wilson EE, Verheule S, Guerra JM, Foreman S, Olgin JE. Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am J Physiol Heart Circ Physiol. 2006;291:H2911–23.CrossRefPubMed
21.
Zurück zum Zitat Liang JJ, Elafros MA, Muser D, Pathak RK, Santangeli P, Zado ES, Frankel DS, Supple GE, Schaller RD, Deo R, Garcia FC, Lin D, Hutchinson MD, Riley MP, Callans DJ, Marchlinski FE, Dixit S. pulmonary vein antral isolation and nonpulmonary vein trigger ablation are sufficient to achieve favorable long-term outcomes including transformation to paroxysmal arrhythmias in patients with persistent and long-standing persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9. Liang JJ, Elafros MA, Muser D, Pathak RK, Santangeli P, Zado ES, Frankel DS, Supple GE, Schaller RD, Deo R, Garcia FC, Lin D, Hutchinson MD, Riley MP, Callans DJ, Marchlinski FE, Dixit S. pulmonary vein antral isolation and nonpulmonary vein trigger ablation are sufficient to achieve favorable long-term outcomes including transformation to paroxysmal arrhythmias in patients with persistent and long-standing persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9.
22.
Zurück zum Zitat Muellerleile K, Groth M, Steven D, Hoffmann BA, Saring D, Radunski UK, Lund GK, Adam G, Rostock T, Willems S. Cardiovascular magnetic resonance demonstrates reversible atrial dysfunction after catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24:762–7. https://doi.org/10.1111/jce.12125.CrossRefPubMed Muellerleile K, Groth M, Steven D, Hoffmann BA, Saring D, Radunski UK, Lund GK, Adam G, Rostock T, Willems S. Cardiovascular magnetic resonance demonstrates reversible atrial dysfunction after catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24:762–7. https://​doi.​org/​10.​1111/​jce.​12125.CrossRefPubMed
23.
Zurück zum Zitat Pump A, Di Biase L, Price J, Mohanty P, Bai R, Santangeli P, Mohanty S, Trivedi C, Yan RX, Horton R, Sanchez JE, Zagrodzky J, Bailey S, Gallinghouse GJ, Burkhardt JD, Natale A. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling. J Cardiovasc Electrophysiol. 2013;24:1224–31. https://doi.org/10.1111/jce.12253.CrossRefPubMed Pump A, Di Biase L, Price J, Mohanty P, Bai R, Santangeli P, Mohanty S, Trivedi C, Yan RX, Horton R, Sanchez JE, Zagrodzky J, Bailey S, Gallinghouse GJ, Burkhardt JD, Natale A. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling. J Cardiovasc Electrophysiol. 2013;24:1224–31. https://​doi.​org/​10.​1111/​jce.​12253.CrossRefPubMed
24.
27.
Zurück zum Zitat Leong-Sit P, Roux JF, Zado E, Callans DJ, Garcia F, Lin D, Marchlinski FE, Bala R, Dixit S, Riley M, Hutchinson MD, Cooper J, Russo AM, Verdino R, Gerstenfeld EP. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm ElectrophEberlyysiol. 2011;4:11–4.CrossRef Leong-Sit P, Roux JF, Zado E, Callans DJ, Garcia F, Lin D, Marchlinski FE, Bala R, Dixit S, Riley M, Hutchinson MD, Cooper J, Russo AM, Verdino R, Gerstenfeld EP. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm ElectrophEberlyysiol. 2011;4:11–4.CrossRef
30.
Zurück zum Zitat Rivard L, Hocini M, Rostock T, Cauchemez B, Forclaz A, Jadidi AS, Linton N, Nault I, Miyazaki S, Liu X, Xhaet O, Shah A, Sacher F, Derval N, Jaïs P, Khairy P, Macle L, Nattel S, Willems S, Haïssaguerre M. Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study. Heart Rhythm. 2012Jul;9(7):1025–30. https://doi.org/10.1016/j.hrthm.2012.02.016.CrossRefPubMed Rivard L, Hocini M, Rostock T, Cauchemez B, Forclaz A, Jadidi AS, Linton N, Nault I, Miyazaki S, Liu X, Xhaet O, Shah A, Sacher F, Derval N, Jaïs P, Khairy P, Macle L, Nattel S, Willems S, Haïssaguerre M. Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study. Heart Rhythm. 2012Jul;9(7):1025–30. https://​doi.​org/​10.​1016/​j.​hrthm.​2012.​02.​016.CrossRefPubMed
Metadaten
Titel
Presence of sinus rhythm at time of ablation in patients with persistent atrial fibrillation undergoing pulmonary vein isolation is associated with improved long-term arrhythmia outcomes
verfasst von
Lauren A. Eberly
Aung Lin
Joseph Park
Mirmilad Khoshnab
Lohit Garg
Jennifer Chee
Michael J. Kallan
Katie Walsh
Gregory E. Supple
Robert D. Schaller
Pasquale Santangeli
Michael P. Riley
Saman Nazarian
Jeffrey Arkles
Matthew Hyman
David Lin
Gustavo Guandalini
Ramanan Kumareswaran
Rajat Deo
Erica S. Zado
Andrew Epstein
David S. Frankel
David J. Callans
Francis E. Marchlinski
Sanjay Dixit
Publikationsdatum
16.12.2022
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 6/2023
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-022-01441-4

Weitere Artikel der Ausgabe 6/2023

Journal of Interventional Cardiac Electrophysiology 6/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.